SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-22-074030
Filing Date
2022-11-21
Accepted
2022-11-21 08:51:18
Documents
1
Period of Report
2022-11-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 3  
1 OWNERSHIP DOCUMENT ownership.xml 3 3362
  Complete submission text file 0001213900-22-074030.txt   4723
Mailing Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022
Business Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Issuer) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4300 EL CAMINO REAL SUITE 210 LOS ALTOS CA 94022
Business Address
Jermasek Douglas (Reporting) CIK: 0001955273 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40582 | Film No.: 221403615